Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Knatterud

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|April 27, 1979
Diabetes drugs: clinical trialT E Prout, G L Knatterud, C G Meinert
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Design of data formsG L Knatterud, S A Forman, P L Canner
Journal of the American College of Cardiology|February 1, 1986
Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirinC R Klimt, G L Knatterud, J Stamler, et al.
Journal of the American College of Cardiology|February 1, 1987
Announcement of protocol change in thrombolysis in myocardial infarction trialE Braunwald, G L Knatterud, E R Passamani, et al.
Diabetes|January 1, 1970
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality resultsC L Meinert, G L Knatterud, T E Prout, et al.
Diabetes|October 1, 1972
The UGDP controversy. Clinical trials versus clinical impressionsT E Prout, G L Knatterud, C L Meinert, et al.
Diabetes Care|March 1, 1979
The UGDP and insulin therapy: a replyG L Knatterud, C R Klimt, M E Jacobson, et al.
Journal of the American College of Cardiology|October 1, 1987
Update from the Thrombolysis in Myocardial Infarction TrialE Braunwald, G L Knatterud, E Passamani, et al.
Controlled Clinical Trials|August 1, 1997
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.
JAMA|August 9, 1971
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin resultsG L Knatterud, C L Meinert, C R Klimt, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|April 27, 1979
Diabetes drugs: clinical trialT E Prout, G L Knatterud, C G Meinert
Controlled Clinical Trials|December 1, 1983
The Coronary Drug Project. Design of data formsG L Knatterud, S A Forman, P L Canner
Journal of the American College of Cardiology|February 1, 1986
Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirinC R Klimt, G L Knatterud, J Stamler, et al.
Journal of the American College of Cardiology|February 1, 1987
Announcement of protocol change in thrombolysis in myocardial infarction trialE Braunwald, G L Knatterud, E R Passamani, et al.
Diabetes|January 1, 1970
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality resultsC L Meinert, G L Knatterud, T E Prout, et al.
Diabetes|October 1, 1972
The UGDP controversy. Clinical trials versus clinical impressionsT E Prout, G L Knatterud, C L Meinert, et al.
Diabetes Care|March 1, 1979
The UGDP and insulin therapy: a replyG L Knatterud, C R Klimt, M E Jacobson, et al.
Journal of the American College of Cardiology|October 1, 1987
Update from the Thrombolysis in Myocardial Infarction TrialE Braunwald, G L Knatterud, E Passamani, et al.
Controlled Clinical Trials|August 1, 1997
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.
JAMA|August 9, 1971
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin resultsG L Knatterud, C L Meinert, C R Klimt, et al.
Pageof 8